Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.740
+0.150 (3.27%)
Apr 13, 2026, 1:08 PM EDT - Market open
Foghorn Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts that cover Foghorn Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $11.5, which forecasts a 142.62% increase in the stock price over the next year. The lowest target is $9.00 and the highest is $13.
Price Target: $11.5 (+142.62%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 12, 2026.
Analyst Ratings
The average analyst rating for Foghorn Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $10 | Buy | Reiterates | $10 | +110.97% | Mar 12, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +174.26% | Mar 10, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +153.16% | Feb 17, 2026 |
| BTIG | BTIG | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +132.07% | Dec 18, 2025 |
| Stifel | Stifel | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +153.16% | Dec 4, 2025 |
Financial Forecast
Revenue This Year
33.32M
from 30.91M
Increased by 7.81%
Revenue Next Year
39.23M
from 33.32M
Increased by 17.72%
EPS This Year
-1.13
from -1.18
EPS Next Year
-1.11
from -1.13
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 52.5M | 52.5M | |||
| Avg | 33.3M | 39.2M | |||
| Low | n/a | 19.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 69.9% | 57.5% | |||
| Avg | 7.8% | 17.7% | |||
| Low | - | -41.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.97 | -0.70 | |||
| Avg | -1.13 | -1.11 | |||
| Low | -1.54 | -1.53 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.